Alimera Sciences (ALIM) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to loss of $0.44 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -100%. A quarter ago, it was expected that this eye drug developer would post a loss of $0.04 per share when it actually produced a loss of $0.12, delivering a surprise of -200%.Over the last four quarters, the company ha ...